Overview of LBR: Potential Drug Target and Biomarker (G3930)

Target Name: LBR

NCBI ID: G3930

Content of Review Report on LBR Target / Biomarker

LBR

Overview of LBR: Potential Drug Target and Biomarker

LBR (Leucine-rich repeat) is a protein that is expressed in various tissues throughout the body. It is characterized by a unique repeat sequence, which is composed of 20-30 amino acids. LBR has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Purpose of the Article

The purpose of this article is to provide an overview of LBR, its potential drug target status, and its role as a biomarker. The article will cover the structure and function of LBR, its potential clinical applications, and current research efforts in the field.

Structure and Function

LBR is a protein that is expressed in various tissues throughout the body, including the brain, muscle, heart, liver, and kidney. It is typically synthesized in the cytoplasm and secreted into the extracellular medium through the secretory pathway.

One of the unique features of LBR is its repeat sequence, which is composed of 20-30 amino acids. The repeat sequence is located at the C-terminus of the protein and consists of the amino acids Asp-21, Asp-22, Asp -23, Asp-24, Asp-25, Asp-26, Asp-27, Asp-28, Asp-29, Asp-30, Asp-31, Asp-32, Asp-33, Asp-34, Asp-35 , Asp-36, Asp-37, Asp-38, Asp-39, Asp-40, and Asp-41.

The LBR repeat is also known as the leucine-rich repeat (LRR) and is a common protein motif that is found in various proteins, including nuclear proteins, cytoplasmic proteins, and transmembrane proteins. LBR has been identified as a potential drug target due to its unique structure and the potential interactions it may have with various signaling pathways.

Potential Clinical Applications

LBR has been identified as a potential drug target due to its unique structure and the potential interactions it may have with various signaling pathways. One of the primary goals of drug development is to identify compounds that can modulate the activity of a protein and improve its function , or to identify compounds that can inhibit the activity of a protein and decrease its function.

There is a growing interest in using small molecules, such as drugs, to modulate the activity of LBR. Small molecules can interact with LBR to alter its stability, localization, or activity. This has led to the development of various compounds that have been shown to interact with LBR.

In addition to its potential as a drug target, LBR has also been identified as a potential biomarker for various diseases. The LBR repeat is a common protein motif that is found in various proteins, including nuclear proteins, cytoplasmic proteins, and transmembrane proteins. This suggests that LBR may be a useful biomarker for certain diseases.

Current Research Efforts

Current research efforts are focused on the development of small molecules that can modulate the activity of LBR. Many studies have been conducted to identify potential drugs that can interact with LBR. These studies have led to the development of various compounds, including small molecules, peptides , and antibodies.

In addition to its potential as a drug target, LBR has also been identified as a potential biomarker for various diseases. Researchers have used various techniques, such as Western blotting and immunofluorescence, to demonstrate the expression of LBR in various tissues and to study its potential as a biomarker.

Conclusion

LBR is a protein that is characterized by a unique repeating sequence, which is composed of 20-30 amino acids. It has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Current research efforts are focused on the development of small molecules that can modulate the activity of LBR and the study of its potential as a biomarker. Further research is needed to fully understand the role of LBR in disease and to develop effective treatments.

Protein Name: Lamin B Receptor

Functions: Catalyzes the reduction of the C14-unsaturated bond of lanosterol, as part of the metabolic pathway leading to cholesterol biosynthesis (PubMed:9630650, PubMed:12618959, PubMed:16784888, PubMed:21327084, PubMed:27336722). Plays a critical role in myeloid cell cholesterol biosynthesis which is essential to both myeloid cell growth and functional maturation (By similarity). Mediates the activation of NADPH oxidases, perhaps by maintaining critical levels of cholesterol required for membrane lipid raft formation during neutrophil differentiation (By similarity). Anchors the lamina and the heterochromatin to the inner nuclear membrane (PubMed:10828963)

The "LBR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LBR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets